Elevance Health, Inc. (ELV)
| Market Cap | 96.28B |
| Revenue (ttm) | 176.81B |
| Net Income (ttm) | 5.98B |
| Shares Out | 227.35M |
| EPS (ttm) | 25.68 |
| PE Ratio | 16.49 |
| Forward PE | 12.28 |
| Dividend | $6.84 (1.62%) |
| Ex-Dividend Date | Mar 10, 2025 |
| Volume | 847,612 |
| Open | 427.78 |
| Previous Close | 427.23 |
| Day's Range | 419.53 - 428.95 |
| 52-Week Range | 362.21 - 567.26 |
| Beta | 0.87 |
| Analysts | Buy |
| Price Target | 530.83 (+25.3%) |
| Earnings Date | Apr 17, 2025 |
About ELV
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, a... [Read more]
Financial Performance
In 2024, Elevance Health's revenue was $176.81 billion, an increase of 3.19% compared to the previous year's $171.34 billion. Earnings were $5.98 billion, a decrease of -0.12%.
Financial StatementsAnalyst Forecast
According to 15 analysts, the average rating for ELV stock is "Buy." The 12-month stock price forecast is $530.83, which is an increase of 25.30% from the latest price.
News
Elevance Health: Add A Little Bit Of Health To Your Defensive Portfolio
Elevance Health remains a buy with its strong fundamentals. An added bonus is its defensive nature during the tariff wars. Regulatory changes under Trump's administration and AI integration are key fa...
Maximizing Returns: 3 Compelling Reasons To Invest In Elevance Health Now
Due to heightened political uncertainty, health insurer and pharmacy benefit manager, Elevance Health, continues to be shunned by the market. While I focused on the challenges and risks in my last art...
U.S. Managed Care Q4 2024 Earnings Recap: Medical Costs Continue To Mount
US managed care insurers' fourth quarter 2024 earnings season was characterized by generally higher medical costs amid ongoing changes to federally subsidized healthcare plans that, in some cases, res...
Defensive, Sector-Based Dividend Growth: 6 Opportunities And One Special Highlight (Part 1)
Dividend growth investing can offer high-quality stocks, with small dividends growing in the 10-15% range, providing impressive investment opportunities. Diversified, large-cap companies with strong r...
Elevance Health Bolsters Employer Insurance Business
Elevance Health says its acquisition of Verily's Granular Insurance Company is designed to bolster its offerings to self-funded employer clients. Financial terms of the deal aren't being disclosed, an...
Alphabet's Verily to sell Granular insurance business to Elevance Health
Alphabet's Verily is selling its subsidiary, Granular Insurance Company, to Elevance Health. Verily launched Granular in 2020 with financial backing from the commercial insurance unit of the Swiss Re ...
Elevance Health Foundation Announces New Five-Year, $150 Million Commitment
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health Foundation today announces its new five-year, $150 million commitment aimed at addressing the physical, behavioral, and social needs of under-resourced c...
My Top 15 High-Growth Dividend Stocks For February 2025
The SPDR S&P 500 ETF Trust starts 2025 on a positive note gaining 2.67% in January. The Top 15 dividend growth stocks for February 2025 offer an average dividend yield of 1.64% and appear to be about ...
Elevance Health, Inc. (ELV) Q4 2024 Earnings Call Transcript
Elevance Health, Inc. (NYSE:ELV) Q4 2024 Earnings Conference Call January 23, 2025 8:30 AM ET Company Participants Nathan Rich - VP, IR Gail Boudreaux - President & CEO Mark Kaye - CFO Felicia Norwoo...
Elevance Health Stock Rises as Company Tops Estimates, Raises Dividend
Shares of Elevance Health (ELV) advanced Thursday after the health insurance provider reported better-than-anticipated results on higher premiums, acquisitions, and growth of its pharmacy coverage uni...
GE Orders Soar, EA Slashes Guidance, ELV Ups Dividend
GE Aerospace (GE) jumped to levels it hasn't seen since 2007. The company posted an earnings beat and total orders that impressed investors.
Elevance Health Posts Q4 Profit Despite Medicaid Drop, Rising Costs; Hikes Dividend 5%
On Thursday, Elevance Health Inc. ELV reported fourth-quarter revenues of $44.99 billion, up 6% year-over-year, slightly higher than the consensus of $44.86 billion.
Elevance Health Q4 2024 Earnings: Managed Care Continues To Impress
Despite a 29% drop in Elevance Health's stock, I maintain a strong buy rating due to a DCF price target of $549.60, indicating 43% upside. ELV's shift towards managed care, with strong industry tailwi...
Elevance Stock Gains After Strong Quarter. A Dividend Hike Is Another Positive.
The health insurer's fourth-quarter adjusted earnings top analysts' estimates.
Elevance Health earnings boost health-insurance stocks after upbeat outlook
UnitedHealth, Humana and Centene all rally premarket
Elevance Health 2024 Profits Hit $6 Billion Despite Rising Costs
Elevance Health reported nearly $6 billion in 2024 profits including $418 million in the fourth quarter as the health insurer worked to overcome rising medical expense from patients in its Medicaid pl...
Elevance beats quarterly profit estimates on lower-than-expected medical costs
Elevance beat Wall Street estimates for quarterly profit on Thursday, as the health insurer spent less than expected on the medical costs of its members.
Elevance Health Reports Fourth Quarter and Full Year 2024 Results; Sets Full Year 2025 Outlook
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported fourth quarter and full year 2024 results. “As part of our commitment to elevating whole health and advancing health beyond he...
Mark Farrah Associates Delves into Acquisition Impacts Utilizing New Tools
CANONSBURG, Pa.--(BUSINESS WIRE)--MFA reviewed Elevance Health's acquisition of Indiana University Health Plans using Medicare Benefits Analyzer and County Health Coverage.
Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2024 Results on January 23, 2025
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release fourth quarter and full year 2024 financial results on January 23, 2025, at 6:00 a.m. Eastern Standard Time (“EST”). Management ...
My Top 15 High Growth Dividend Stocks For January 2025
The SPDR S&P 500 ETF Trust ended 2024 on a sour note, losing 2.41% in December and finishing the year up 24.89%. The Top 15 dividend growth stocks for January 2025 offer an average dividend yield of 1...
Elevance Health Is An Undervalued Healthcare Juggernaut
Elevance Health is a strong buy despite a 30% stock decline, due to its solid fundamentals and market position in the health insurance industry. The company benefits from secular trends like an aging ...
Santa's Stunning Stocking Surprises: 5 High Yield Blue-Chip Bargains For 2025
Investing in blue-chip stocks at 52-week lows can potentially yield significant returns if fundamentals are strong. Avoid value traps by focusing on companies with solid fundamentals, like Elevance He...
Robbins LLP Informs Elevance Health Inc. Stockholders that it is Investigating the Officers and Directors of ELV to Determine if They Breached Fiduciary Duties Owed to Shareholders
SAN DIEGO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating Elevance Health Inc. (NASDAQ: ELV) to determine whether certain Elevance officers and directors vi...